1. Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients

   ICC, Kreijne, J. E., de Vries, A. C., de Veer, R. C., Bouma, G., Dijkstra, G., Voskuil, M. D., West, R., van Moorsel, S. A. W., de Jong, D. J., de Boer, N. K. & van der Woude, C. J., 1-Jun-2020, In : Alimentary Pharmacology & Therapeutics. 51, 12, p. 1353-1364 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study

   Dutch Initiative on Crohn and Colitis, Asscher, V. E. R., Biemans, V. B. C., Pierik, M. J., Dijkstra, G., Löwenberg, M., van der Marel, S., de Boer, N. K. H., Bodelier, A. G. L., Jansen, J. M., West, R. L., Haans, J. J. L., van Dop, W. A., Weersma, R. K., Hoentjen, F. & Maljaars, P. W. J., 2020, In : Alimentary Pharmacology & Therapeutics. 52, 8, p. 1366-1376 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

   Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., Sleutjes, J. A. M., de Vries, A. C., Bodelier, A. G. L., Dijkstra, G., Oldenburg, B., Löwenberg, M., van Bodegraven, A. A., van der Meulen-de Jong, A. E., de Boer, N. K. H., Srivastava, N., West, R. L., Römkens, T. E. H., Horjus Talabur Horje, C. S., Jansen, J. M., van der Woude, C. J., Hoekstra, J., Weersma, R. K., van Schaik, F. D. M., Hoentjen, F. & Pierik, M. J., 1-May-2020, In : Alimentary Pharmacology & Therapeutics. 51, 9, p. 880-888 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease

   Bangma, A., Voskuil, M. D., Uniken Venema, W. T. C., Brugge, H., Hu, S., Lanting, P., Franke, L., Dijkstra, G., Festen, E. A. M. & Weersma, R. K., Jun-2020, In : Alimentary Pharmacology & Therapeutics. 51, 11, p. 1105-1115 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment

   Dutch Initiative on Crohn and Colitis, Biemans, V. B. C., van der Woude, C. J., Dijkstra, G., van der Meulen-de Jong, A. E., Lowenberg, M., de Boer, N. K., Oldenburg, B., Srivastava, N., Jansen, J. M., Bodelier, A. G. L., West, R. L., de Vries, A. C., Haans, J. J. L., de Jong, D., Hoentjen, F. & Pierik, M. J., Jul-2020, In : Alimentary Pharmacology & Therapeutics. 52, 1, p. 123-134 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (66) »